(Q44400977)

2 December 2017

title

The influence of olanzapine on immune cells in patients with schizophrenia (English)

1 reference

2 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0278-5846(03)00036-8

23 December 2023

1

Mustafa Bilici

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691784

23 December 2023

author name string

Yavuz Tekelioğlu

2

1 reference

2 December 2017

Saniye Efendioğlu

3

1 reference

2 December 2017

Ercüment Ovali

4

1 reference

2 December 2017

Metin Ulgen

5

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691784

23 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0278584603000368?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0278-5846(03)00036-8

https://api.elsevier.com/content/article/PII:S0278584603000368?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0278-5846(03)00036-8

Progress in Neuro-Psychopharmacology & Biological Psychiatry

23 December 2023

published in

1 reference

2 December 2017

volume

27

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

483-485

1 reference

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Treatment-resistant schizophrenia--the role of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Effects of antipsychotic drugs on cytokine networks

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Rechallenge in clozapine-induced agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900036-8

7 January 2021

Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis

5

1 reference

https://api.crossref.org/works/10.1016/S0278-5846(03)00036-8

23 December 2023

Identifiers

1 reference

2 December 2017

1 reference